Cargando…
Neutrophil-mediated clinical nanodrug for treatment of residual tumor after focused ultrasound ablation
BACKGROUND: The risk of local recurrence after high-intensity focused ultrasound (HIFU) is relatively high, resulting in poor prognosis of malignant tumors. The combination of HIFU with traditional chemotherapy continues to have an unsatisfactory outcome because of off-site drug uptake. RESULTS: Her...
Autores principales: | Shen, Jian, Hao, Junnian, Chen, Yini, Liu, Hairong, Wu, Jianrong, Hu, Bing, Wang, Yan, Zheng, Yuanyi, Cai, Xiaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555249/ https://www.ncbi.nlm.nih.gov/pubmed/34715854 http://dx.doi.org/10.1186/s12951-021-01087-w |
Ejemplares similares
-
CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy
por: Chang, Yun, et al.
Publicado: (2023) -
Biodegradable reduce expenditure bioreactor for augmented sonodynamic therapy via regulating tumor hypoxia and inducing pro-death autophagy
por: Zou, Weijuan, et al.
Publicado: (2021) -
Correction: Biodegradable reduce expenditure bioreactor for augmented sonodynamic therapy via regulating tumor hypoxia and inducing pro‑death autophagy
por: Zou, Weijuan, et al.
Publicado: (2022) -
Self-synergistic effect of Prussian blue nanoparticles for cancer therapy: driving photothermal therapy and reducing hyperthermia-induced side effects
por: Xie, Xue, et al.
Publicado: (2021) -
Ultrasound Triggering of Liposomal Nanodrugs for Cancer Therapy: A Review
por: Bahutair, Wafa N., et al.
Publicado: (2022)